Table 6.

Risk factors associated with persistence of fatigue after 6 months of levothyroxine replacement therapy.

	Relative Risk	95% Confidence Interval	p Value
FSS > 34	3.9	1.43–10.73	0.008 *
FSS > 36	3.2	1.21–8.6	0.019 *
Diabetes	5.7	1.25–9.6	0.024 *
Hypertension	1.1	0.25–4.7	0.89
Obesity	1.16	0.20–1.27	0.22
Rheumatoid arthritis	1.2	0.1–47	0.78
Fibromyalgia	0.9	0.3–28	0.82

FSS: fatigue severity scale. * p > 0.05 = statistical significance.